LEADER 04926nam 2200961 450 001 9910788186103321 005 20230807204928.0 010 $a0-520-96081-5 024 7 $a10.1525/9780520960817 035 $a(CKB)2670000000594516 035 $a(EBL)1939109 035 $a(SSID)ssj0001421539 035 $a(PQKBManifestationID)12606365 035 $a(PQKBTitleCode)TC0001421539 035 $a(PQKBWorkID)11424109 035 $a(PQKB)10525965 035 $a(MiAaPQ)EBC1939109 035 $a(DE-B1597)520704 035 $a(OCoLC)903206522 035 $a(DE-B1597)9780520960817 035 $a(Au-PeEL)EBL1939109 035 $a(CaPaEBR)ebr11020999 035 $a(CaONFJC)MIL727581 035 $a(EXLCZ)992670000000594516 100 $a20150227h20152015 uy 0 101 0 $aeng 135 $aur|nu---|u||u 181 $ctxt 182 $cc 183 $acr 200 10$aPurchasing medical innovation $ethe right technology, for the right patient, at the right price /$fJames C. Robinson 210 1$aOakland, California :$cUniversity of California Press,$d2015. 210 4$dİ2015 215 $a1 online resource (183 p.) 300 $aIncludes index. 311 0 $a0-520-28166-7 311 0 $a1-322-96299-5 327 $tFront matter --$tContents --$tList of Illustrations --$tAcknowledgments --$tIntroduction --$t1. Regulatory Access to the Market --$t2. Insurance Coverage and Reimbursement --$t3. Methods of Payment for Medical Technology --$t4. The Hospital as Purchaser --$t5. Organizational Capabilities for Technology Purchasing --$t6. The Patient as Purchaser --$t7. Implications for the Medical Technology Industry --$tNotes --$tIndex 330 $aInnovation in medical technology generates a remarkable supply of new drugs, devices, and diagnostics that improve health, reduce risks, and extend life. But these technologies are too often used on the wrong patient, in the wrong setting, or at an unaffordable price. The only way to moderate the growth in health care costs without undermining the dynamic of medical innovation is to improve the process of assessing, pricing, prescribing, and using new technologies. Purchasing Medical Innovation analyzes the contemporary revolution in the purchasing of health care technology, with a focus on the roles of the Food and Drug Administration (FDA), Medicare and private health insurers, physicians and hospitals, and consumers themselves. The FDA is more thoroughly assessing product performance under real-world conditions as well as in laboratory settings, accelerating the path to market for breakthroughs while imposing use controls on risky products. Insurers are improving their criteria for coverage and designing payment methods that reward efficiency in the selection of new treatments. Hospitals are aligning adoption of complex supplies and equipment more closely with physicians' preferences for the best treatment for their patients. Consumers are becoming more engaged and financially accountable for their health care choices. This book describes both the strengths and deficiencies of the current system of purchasing and highlights opportunities for buyers, sellers, and users to help improve the value of medical technology: better outcomes at lower cost. 606 $aMedical technology$xCost control 606 $aMedical innovations$xCost control 606 $aMedical care, Cost of 606 $aMedical care$xCost control 606 $aHealth care reform 606 $aHealth insurance 610 $aartificial heart valves. 610 $acost of medical technology. 610 $acost of medical treatment. 610 $aeconomics of healthcare. 610 $ahealth care costs. 610 $ahealth care reform. 610 $ahealth insurance. 610 $ahealth policy. 610 $ahip replacement. 610 $aimproving patient care. 610 $ainnovative medical care. 610 $ainsurance coverage for medical care. 610 $ajoint replacement. 610 $aknee replacement. 610 $amedical care. 610 $amedical costs. 610 $amedical economics. 610 $amedical innovation. 610 $amedical market access. 610 $amedical technology industry. 610 $amedical technology. 610 $apatient care. 610 $aprice of medical technology. 615 0$aMedical technology$xCost control. 615 0$aMedical innovations$xCost control. 615 0$aMedical care, Cost of. 615 0$aMedical care$xCost control. 615 0$aHealth care reform. 615 0$aHealth insurance. 676 $a610.28 700 $aRobinson$b James C$g(James Claude),$f1953-$01100077 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910788186103321 996 $aPurchasing medical innovation$93712861 997 $aUNINA